Veronica S. Gil

London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

NXP800 Activates the Unfolded Protein Response, Altering AR and E2F Function to Impact Castration-Resistant Prostate Cancer Growth.

NXP800 Activates the Unfolded Protein Response, Altering AR and E2F Function to Impact Castration-Resistant Prostate Cancer Growth.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: July 29, 2024

Immune Biomarkers in Metastatic Castration-resistant Prostate Cancer.

Immune Biomarkers in Metastatic Castration-resistant Prostate Cancer.

Journal: European urology oncology

Published: January 21, 2022

Suppression of MYC by PI3K/AKT/mTOR pathway inhibition in combination with all-trans retinoic acid treatment for therapeutic gain in acute myeloid leukaemia.

Suppression of MYC by PI3K/AKT/mTOR pathway inhibition in combination with all-trans retinoic acid treatment for therapeutic gain in acute myeloid leukaemia.

Journal: British journal of haematology

Published: January 13, 2022

Prostate-Specific Membrane Antigen Expression and Response to DNA Damaging Agents in Prostate Cancer.

Prostate-Specific Membrane Antigen Expression and Response to DNA Damaging Agents in Prostate Cancer.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: December 28, 2021

HER3 Is an Actionable Target in Advanced Prostate Cancer.

HER3 Is an Actionable Target in Advanced Prostate Cancer.

Journal: Cancer research

Published: October 04, 2021

CD38 in Advanced Prostate Cancers.

CD38 in Advanced Prostate Cancers.

Journal: European urology

Published: August 13, 2020

JMJD6 Is a Druggable Oxygenase That Regulates AR-V7 Expression in Prostate Cancer.

JMJD6 Is a Druggable Oxygenase That Regulates AR-V7 Expression in Prostate Cancer.

Journal: Cancer research

Published: May 28, 2020

Targeting the p300/CBP Axis in Lethal Prostate Cancer.

Targeting the p300/CBP Axis in Lethal Prostate Cancer.

Journal: Cancer discovery

Published: May 27, 2020

Advanced Prostate Cancer with ATM Loss: PARP and ATR Inhibitors.

Advanced Prostate Cancer with ATM Loss: PARP and ATR Inhibitors.

Journal: European urology

Published: May 22, 2020

Genetic Analysis of Circulating Tumour Cells.

Genetic Analysis of Circulating Tumour Cells.

Journal: Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer

Published: October 13, 2019

CDCP1 overexpression drives prostate cancer progression and can be targeted in vivo.

CDCP1 overexpression drives prostate cancer progression and can be targeted in vivo.

Journal: The Journal of clinical investigation

Published: June 18, 2019

Re-education of Tumor-Associated Macrophages by CXCR2 Blockade Drives Senescence and Tumor Inhibition in Advanced Prostate Cancer.

Re-education of Tumor-Associated Macrophages by CXCR2 Blockade Drives Senescence and Tumor Inhibition in Advanced Prostate Cancer.

Journal: Cell reports

Published: December 05, 2018

Showing 1-12 of 22

Last Updated: 09/26/2026